Pub Date : 2025-11-30DOI: 10.1016/j.prmcm.2025.100731
Abhishek Singh , Seema Yadav , Amita Verma , Jagat Pal Yadav , Narahari N. Palei
Huangbai liniment, derived from Phellodendron amurense, is widely recognized for its diverse therapeutic properties, such as reducing inflammation, combating oxidative stress, and promoting wound healing. This review consolidates scientific findings from authoritative databases, including PubMed, Springer Link, Wiley Online Library, Web of Science, the Chinese Electronic Periodical Services Database of Taiwan, Europe PMC, ScienceDirect, Google Scholar, and ClinicalTrials.gov. The therapeutic potential of Huangbai liniment was explored, particularly its role in modulating key cellular pathways, including IL, Nrf2, and TGF-β, which contribute to inflammation regulation and diabetic wound healing. The bioactive constituents of Phellodendron amurense, including alkaloids such as berberine, palmatine, and jatrorrhizine, exhibit significant antimicrobial, anti-inflammatory, and metabolic regulatory activities. Additionally, other active compounds, including lignans, phenolics, and limonoids, contribute to its broad-spectrum efficacy against conditions such as cancer, bacterial and viral infections, neurodegenerative diseases, and metabolic disorders. This review also highlights the available clinical trials. Given the increasing global interest in herbal medicine, particularly in Traditional Chinese Medicine (TCM), further research is necessary to validate its therapeutic potential and facilitate its integration into modern pharmaceutical applications. This review underscores the significance of Huangbai liniment as a promising candidate for drug development, bridging traditional applications with scientific validation for future therapeutic innovations.
黄柏乳膏,源自黄柏,因其多种治疗特性而被广泛认可,如减少炎症,对抗氧化应激,促进伤口愈合。本综述整合了来自PubMed、施普林格Link、Wiley在线图书馆、Web of Science、台湾中文电子期刊服务数据库、欧洲PMC、ScienceDirect、谷歌Scholar和ClinicalTrials.gov等权威数据库的科学发现。探讨了黄柏搽剂的治疗潜力,特别是其在调节关键细胞通路中的作用,包括IL, Nrf2和TGF-β,这些通路有助于炎症调节和糖尿病伤口愈合。黄柏的生物活性成分,包括小檗碱、棕榈碱和黄根碱等生物碱,具有显著的抗菌、抗炎和代谢调节活性。此外,其他活性化合物,包括木脂素、酚类和柠檬素类,有助于其广谱功效,对抗癌症、细菌和病毒感染、神经退行性疾病和代谢紊乱。本综述还重点介绍了现有的临床试验。鉴于全球对草药的兴趣日益增加,特别是对中医(TCM)的兴趣,有必要进一步研究以验证其治疗潜力并促进其与现代制药应用的结合。这篇综述强调了黄柏搽剂作为一种有前途的药物开发候选药物的重要性,它将传统应用与未来治疗创新的科学验证联系起来。
{"title":"The multifaceted therapeutic potential of Huangbai liniment: Modulation of IL, TGF-β and Nrf2 pathways in inflammation downregulation and diabetic wound healing","authors":"Abhishek Singh , Seema Yadav , Amita Verma , Jagat Pal Yadav , Narahari N. Palei","doi":"10.1016/j.prmcm.2025.100731","DOIUrl":"10.1016/j.prmcm.2025.100731","url":null,"abstract":"<div><div>Huangbai liniment, derived from <em>Phellodendron amurense</em>, is widely recognized for its diverse therapeutic properties, such as reducing inflammation, combating oxidative stress, and promoting wound healing. This review consolidates scientific findings from authoritative databases, including PubMed, Springer Link, Wiley Online Library, Web of Science, the Chinese Electronic Periodical Services Database of Taiwan, Europe PMC, ScienceDirect, Google Scholar, and ClinicalTrials.gov. The therapeutic potential of Huangbai liniment was explored, particularly its role in modulating key cellular pathways, including IL, Nrf2, and TGF-β, which contribute to inflammation regulation and diabetic wound healing. The bioactive constituents of <em>Phellodendron amurense</em>, including alkaloids such as berberine, palmatine, and jatrorrhizine, exhibit significant antimicrobial, anti-inflammatory, and metabolic regulatory activities. Additionally, other active compounds, including lignans, phenolics, and limonoids, contribute to its broad-spectrum efficacy against conditions such as cancer, bacterial and viral infections, neurodegenerative diseases, and metabolic disorders. This review also highlights the available clinical trials. Given the increasing global interest in herbal medicine, particularly in Traditional Chinese Medicine (TCM), further research is necessary to validate its therapeutic potential and facilitate its integration into modern pharmaceutical applications. This review underscores the significance of Huangbai liniment as a promising candidate for drug development, bridging traditional applications with scientific validation for future therapeutic innovations.</div></div>","PeriodicalId":101013,"journal":{"name":"Pharmacological Research - Modern Chinese Medicine","volume":"18 ","pages":"Article 100731"},"PeriodicalIF":0.0,"publicationDate":"2025-11-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145750173","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-11-30DOI: 10.1016/j.prmcm.2025.100729
Nur Miftahurrohmah , Catur Riani , Ratna Annisa Utami , Tri Suciati
Introduction
Coix seed (CS), also known as yì yǐ rén or Chinese pearl barley, has been prescribed in traditional Chinese medicine (TCM) for centuries to clear heat, drain dampness, and alleviate inflammatory conditions. It is a key component of classical preparations such as Qing Xin Pei Tu granules and Qin-Zhu-Liang-Xue decoction, traditionally used for atopic eczema and other skin barrier-related disorders. CS has also been applied in topical formulations for acne and chronic ulcers. In modern practice, hydrolyzed and fermented CS products are increasingly utilized for their potential to enhance skin health. However, the mechanisms by which they influence skin barrier function and dermal wound healing remain poorly understood. This study aimed to investigate the effects of hydrolyzed CS and its fermented derivatives on skin barrier gene expression and dermal wound healing, thereby providing scientific support for their cosmetic application.
Methods
CS was hydrolyzed using mild acid, supplemented with yeast extract, and fermented with Lactiplantibacillus plantarum TKK. The non-fermented CS hydrolysate (NF-AC10Y), fermented cell-free supernatant (FF-AC10Y), and fermented cell lysate supernatant (FL-AC10Y) were evaluated in vitro for their effects on skin barrier genes (FLG/pro-filaggrin, IVL/involucrin, and LOR/loricrin), dermal wound healing, and oxidative stress protection. Potential metabolites contributing to the bioactivities were also identified.
Results
FF-AC10Y exhibited the strongest activity. It upregulated FLG, IVL, and LOR mRNA levels in HaCaT keratinocytes by 2.29 ± 0.19-, 1.20 ± 0.08-, and 2.50 ± 0.04-fold, respectively, and achieved 88.1 ± 6.8 % wound closure in NIH/3T3 fibroblasts. It exhibited no cytotoxicity up to 5 mg/mL and protected both cell types against H₂O₂-induced oxidative stress. Metabolite analysis revealed lactic acid, saccharides, amino acids, fatty acid amides, and low-molecular-weight antioxidants as potential contributors to its bioactivities.
Discussion
FF-AC10Y demonstrates strong potential to reinforce the skin barrier by upregulating FLG, IVL, and LOR expression, supporting wound healing, and providing antioxidant protection. These findings scientifically validate the traditional use of CS in TCM for alleviating skin barrier disorders and clarify its mechanisms, bridging historical applications with modern cosmetic formulations.
{"title":"Fermented Coix seed hydrolysate upregulates skin barrier genes and promotes wound healing","authors":"Nur Miftahurrohmah , Catur Riani , Ratna Annisa Utami , Tri Suciati","doi":"10.1016/j.prmcm.2025.100729","DOIUrl":"10.1016/j.prmcm.2025.100729","url":null,"abstract":"<div><h3>Introduction</h3><div>Coix seed (CS), also known as <em>yì yǐ rén</em> or Chinese pearl barley, has been prescribed in traditional Chinese medicine (TCM) for centuries to clear heat, drain dampness, and alleviate inflammatory conditions. It is a key component of classical preparations such as <em>Qing Xin Pei Tu</em> granules and <em>Qin-Zhu-Liang-Xue</em> decoction, traditionally used for atopic eczema and other skin barrier-related disorders. CS has also been applied in topical formulations for acne and chronic ulcers. In modern practice, hydrolyzed and fermented CS products are increasingly utilized for their potential to enhance skin health. However, the mechanisms by which they influence skin barrier function and dermal wound healing remain poorly understood. This study aimed to investigate the effects of hydrolyzed CS and its fermented derivatives on skin barrier gene expression and dermal wound healing, thereby providing scientific support for their cosmetic application.</div></div><div><h3>Methods</h3><div>CS was hydrolyzed using mild acid, supplemented with yeast extract, and fermented with <em>Lactiplantibacillus plantarum</em> TKK. The non-fermented CS hydrolysate (NF-AC10Y), fermented cell-free supernatant (FF-AC10Y), and fermented cell lysate supernatant (FL-AC10Y) were evaluated <em>in vitro</em> for their effects on skin barrier genes (<em>FLG</em>/pro-filaggrin, <em>IVL</em>/involucrin, and <em>LOR</em>/loricrin), dermal wound healing, and oxidative stress protection. Potential metabolites contributing to the bioactivities were also identified.</div></div><div><h3>Results</h3><div>FF-AC10Y exhibited the strongest activity. It upregulated <em>FLG, IVL,</em> and <em>LOR</em> mRNA levels in HaCaT keratinocytes by 2.29 ± 0.19-, 1.20 ± 0.08-, and 2.50 ± 0.04-fold, respectively, and achieved 88.1 ± 6.8 % wound closure in NIH/3T3 fibroblasts. It exhibited no cytotoxicity up to 5 mg/mL and protected both cell types against H₂O₂-induced oxidative stress. Metabolite analysis revealed lactic acid, saccharides, amino acids, fatty acid amides, and low-molecular-weight antioxidants as potential contributors to its bioactivities.</div></div><div><h3>Discussion</h3><div>FF-AC10Y demonstrates strong potential to reinforce the skin barrier by upregulating <em>FLG, IVL,</em> and <em>LOR</em> expression, supporting wound healing, and providing antioxidant protection. These findings scientifically validate the traditional use of CS in TCM for alleviating skin barrier disorders and clarify its mechanisms, bridging historical applications with modern cosmetic formulations.</div></div>","PeriodicalId":101013,"journal":{"name":"Pharmacological Research - Modern Chinese Medicine","volume":"18 ","pages":"Article 100729"},"PeriodicalIF":0.0,"publicationDate":"2025-11-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145694952","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Elaeagnus rhamnoides (sea buckthorn; 沙棘 Shāji) has long been valued in Chinese traditional medicine as fruit purees, decoctions, and polysaccharide granules for enhancing immunity, treating chronic cough, nourishing yin, and promoting digestive and cardiovascular health. However, the precise immunomodulatory mechanisms of its bioactive compounds remain inadequately understood.
Methods
This study comprehensively evaluated key phytocompounds from E. rhamnoides using network pharmacology and in silico computational analysis. Network pharmacology and molecular docking were applied to evaluate interactions with immune checkpoint proteins CTLA-4 (1AH1) and LAG-3 (7TZG). Electronic properties were assessed using density functional theory (DFT) calculations of HOMO–LUMO energy gaps. Molecular dynamics (MD) simulations and MM-GBSA analyses assessed protein–ligand stability and binding energies. ProTox-II toxicity profiling and network pharmacology further elucidated safety and biological pathway associations.
Results
All selected phytocompounds showed strong binding affinities with CTLA-4 and LAG-3, with narcissin, tellimagrandin I, and astragalin demonstrating the most favourable docking scores and molecular interactions. DFT analysis revealed low HOMO–LUMO gaps (3.76–4.82 eV) for strictinin and tellimagrandin I (high chemical reactivity) and higher kinetic stability for astragalin and narcissin. MD simulations confirmed the stability of astragalin complexes, and MM-GBSA revealed that hydrophobic packing and van der Waals forces were the primary drivers of binding affinity. ProTox-II predicted generally low risks of organ toxicity for all compounds. Network pharmacology showed these phytochemicals target multiple core immune-regulatory genes (including NFB1, HIF1A, MAOA, and TLR4) and are involved in critical immunological pathways such as NF-κB, cytokine signalling, and the PD-1/PD-L1 axis.
Discussion
This study provides the first comprehensive in silico systems pharmacology analysis of E. rhamnoides phytocompounds as multi-target, low-toxicity immunomodulators, supporting traditional Chinese medicine applications. The strong and stable binding to immune checkpoints, favorable electronic properties, and multi-pathway engagement reinforce their promise as plant-based immunotherapeutics. These findings support further experimental validation and recommend the featured E. rhamnoides phytocompounds as promising multi-target leads for the development of novel immunomodulatory therapeutics in modern and traditional Chinese medicine contexts.
{"title":"Multi-target immunomodulatory actions of Elaeagnus rhamnoides L.) A. Nelson phytocompounds on immune regulatory targets via integrative network pharmacology, docking, and molecular simulation","authors":"Venkatesan Karthick , Dinesh Kumar Venkatachalam , Singamoorthy Amalraj , Rajkumar Thamarai , Varghese Edwin Hillary , Elsa Shibu Sruthy","doi":"10.1016/j.prmcm.2025.100726","DOIUrl":"10.1016/j.prmcm.2025.100726","url":null,"abstract":"<div><h3>Introduction</h3><div><em>Elaeagnus rhamnoides</em> (sea buckthorn; 沙棘 Shāji) has long been valued in Chinese traditional medicine as fruit purees, decoctions, and polysaccharide granules for enhancing immunity, treating chronic cough, nourishing yin, and promoting digestive and cardiovascular health. However, the precise immunomodulatory mechanisms of its bioactive compounds remain inadequately understood.</div></div><div><h3>Methods</h3><div>This study comprehensively evaluated key phytocompounds from <em>E. rhamnoides</em> using network pharmacology and <em>in silico</em> computational analysis. Network pharmacology and molecular docking were applied to evaluate interactions with immune checkpoint proteins CTLA-4 (1AH1) and LAG-3 (7TZG). Electronic properties were assessed using density functional theory (DFT) calculations of HOMO–LUMO energy gaps. Molecular dynamics (MD) simulations and MM-GBSA analyses assessed protein–ligand stability and binding energies. ProTox-II toxicity profiling and network pharmacology further elucidated safety and biological pathway associations.</div></div><div><h3>Results</h3><div>All selected phytocompounds showed strong binding affinities with CTLA-4 and LAG-3, with narcissin, tellimagrandin I, and astragalin demonstrating the most favourable docking scores and molecular interactions. DFT analysis revealed low HOMO–LUMO gaps (3.76–4.82 eV) for strictinin and tellimagrandin I (high chemical reactivity) and higher kinetic stability for astragalin and narcissin. MD simulations confirmed the stability of astragalin complexes, and MM-GBSA revealed that hydrophobic packing and van der Waals forces were the primary drivers of binding affinity. ProTox-II predicted generally low risks of organ toxicity for all compounds. Network pharmacology showed these phytochemicals target multiple core immune-regulatory genes (including NFB1, HIF1A, MAOA, and TLR4) and are involved in critical immunological pathways such as NF-κB, cytokine signalling, and the PD-1/PD-L1 axis.</div></div><div><h3>Discussion</h3><div>This study provides the first comprehensive <em>in silico</em> systems pharmacology analysis of <em>E. rhamnoides</em> phytocompounds as multi-target, low-toxicity immunomodulators, supporting traditional Chinese medicine applications. The strong and stable binding to immune checkpoints, favorable electronic properties, and multi-pathway engagement reinforce their promise as plant-based immunotherapeutics. These findings support further experimental validation and recommend the featured <em>E. rhamnoides</em> phytocompounds as promising multi-target leads for the development of novel immunomodulatory therapeutics in modern and traditional Chinese medicine contexts.</div></div>","PeriodicalId":101013,"journal":{"name":"Pharmacological Research - Modern Chinese Medicine","volume":"18 ","pages":"Article 100726"},"PeriodicalIF":0.0,"publicationDate":"2025-11-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145799892","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Cognitive impairment associated with aging and neurodegenerative disease is an escalating public health burden, highlighting the need for safe, effective interventions that improve learning and memory. Ocimum basilicum Linn, traditionally used for medicinal purposes, contains bioactive constituents with antioxidant and neuroprotective potential, making it a promising natural candidate for cognition support.
Methods
An integrative design combined in silico network pharmacology and molecular docking with in vivo assessment in Swiss albino mice subjected to haloperidol-induced amnesia. The hydroalcoholic seed extract of Ocimum basilicum was evaluated using validated behavioural paradigms (Morris water maze, Y-maze, passive avoidance, and novel object recognition), complemented by phytochemical screening and histopathological examination of brain tissue.
Results
The extract significantly improved spatial, working, and recognition memory in haloperidol-treated mice. Phytochemical screening indicated abundant flavonoids, saponins, phenols, and tannins; histology showed reduced neuronal damage, supporting a neuroprotective effect consistent with antioxidant activity. In silico analyses revealed strong binding affinities of key phytoconstituents to cognition-related targets and hub proteins, suggesting a multitarget mechanism of action.
Conclusion
These findings indicate that the hydroalcoholic seed extract of Ocimum basilicum confers cognitive enhancement and neuroprotective effects in a haloperidol-induced amnesia model, likely through synergistic, multitarget engagement of antioxidant and anti-apoptotic pathways. Given the rising prevalence of dementia and the limitations of current therapies, further mechanistic studies and clinical trials are warranted to validate the translational potential of basil seed extract as a natural nootropic.
{"title":"Basil seeds unlock memory: Hydroalcoholic extract of Ocimum basilicum reverses haloperidol-induced cognitive deficits in Mice","authors":"Amudha Palanivelu , Balaji V , Durga Mohan , Chetan Ashok , Srikanth Jeyabalan , Ling Shing Wong , Mahendran Sekar , Vetriselvan Subramaniyan , Sivaraman Dhanasekaran , Tamilanban Thamaraikani","doi":"10.1016/j.prmcm.2025.100719","DOIUrl":"10.1016/j.prmcm.2025.100719","url":null,"abstract":"<div><h3>Background</h3><div>Cognitive impairment associated with aging and neurodegenerative disease is an escalating public health burden, highlighting the need for safe, effective interventions that improve learning and memory. <em>Ocimum basilicum</em> Linn, traditionally used for medicinal purposes, contains bioactive constituents with antioxidant and neuroprotective potential, making it a promising natural candidate for cognition support.</div></div><div><h3>Methods</h3><div>An integrative design combined <em>in silico</em> network pharmacology and molecular docking with <em>in vivo</em> assessment in Swiss albino mice subjected to haloperidol-induced amnesia. The hydroalcoholic seed extract of <em>Ocimum basilicum</em> was evaluated using validated behavioural paradigms (Morris water maze, Y-maze, passive avoidance, and novel object recognition), complemented by phytochemical screening and histopathological examination of brain tissue.</div></div><div><h3>Results</h3><div>The extract significantly improved spatial, working, and recognition memory in haloperidol-treated mice. Phytochemical screening indicated abundant flavonoids, saponins, phenols, and tannins; histology showed reduced neuronal damage, supporting a neuroprotective effect consistent with antioxidant activity. <em>In silico</em> analyses revealed strong binding affinities of key phytoconstituents to cognition-related targets and hub proteins, suggesting a multitarget mechanism of action.</div></div><div><h3>Conclusion</h3><div>These findings indicate that the hydroalcoholic seed extract of <em>Ocimum basilicum</em> confers cognitive enhancement and neuroprotective effects in a haloperidol-induced amnesia model, likely through synergistic, multitarget engagement of antioxidant and anti-apoptotic pathways. Given the rising prevalence of dementia and the limitations of current therapies, further mechanistic studies and clinical trials are warranted to validate the translational potential of basil seed extract as a natural nootropic.</div></div>","PeriodicalId":101013,"journal":{"name":"Pharmacological Research - Modern Chinese Medicine","volume":"17 ","pages":"Article 100719"},"PeriodicalIF":0.0,"publicationDate":"2025-11-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145579010","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-11-11DOI: 10.1016/j.prmcm.2025.100718
Dhani Ramachandran , Win Win May , Abu Bakar Abdul Majeed , Sakina Ruhi , Hanish Singh Jayasingh Chellammal
Background
Hesperetin and naringenin are the two flavonoids that are widely applied in Traditional Chinese Medicine (TCM) and mostly found in citrus fruits. Both flavonoids have shown considerable neuroprotective potential. These substances originate from glycosidic precursors, hesperidin and naringin, which are chiefly found in medicinal plants like Zanthoxylum avicennae and Citrus reticulata. In TCM, these botanicals are historically utilized for their analgesic, anti-inflammatory, and digestive properties, but their potential in influencing neurodegenerative processes is receiving growing scrutiny.
Objective
The aim of this review is to cumulate the neuroprotective properties by systematically retrieving the peer-reviewed preclinical and clinical trial research and studies performed in hesperetin and naringenin on multiple mechanisms connected with AD.
Methods
A complete systematic review has been employed by applying MeSH search terms through the application of keywords such as “Alzheimer’s Disease”, “Neuroprotection”, “amyloid”, molecular mechanistic pathways of AD which are discussed in this review and “Clinical trials” for the polyphenols naringenin and hesperetin. Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) analysis method was used for screening of the research studies conducted on naringenin and hesperetin.
Results and discussion
The review retrieved 319 articles in respect to the hesperetin and naringenin on neurodegenerative diseases related to AD. Further scrutinised to 87 with terms of decrease of amyloid-beta aggregation, prevention of tau hyperphosphorylation, mitigation of oxidative stress, and suppression of neuroinflammation. Furthermore, they affect essential molecular cascades, including the PI3K/AKT, NRF2/ARE, and NF-κB signalling pathways, which are intricate for neuronal survival and cognition. It was also found that their ability to cross the blood-brain barrier further amplifies their pharmacological significance in central nervous system illnesses.
Conclusion
Hesperetin and naringenin, as natural multifunctional agents derived from traditional practices, present intriguing opportunities for integrative treatment approaches to AD, connecting the insights of TCM with contemporary neuropharmacology. Further, our review reveals several mechanisms; hesperetin and naringenin are yet to be evaluated in aspects of the hypothalamic-pituitary-adrenal axis (HPA) associated with the stress pathway of neurodegeneration, and exploring the HPA renders additional mechanistic neuroprotective recognition.
{"title":"Traditional wisdom to modern science: Hesperetin and naringenin as emerging traditional Chinese medicine-based treatments for Alzheimer’s disease","authors":"Dhani Ramachandran , Win Win May , Abu Bakar Abdul Majeed , Sakina Ruhi , Hanish Singh Jayasingh Chellammal","doi":"10.1016/j.prmcm.2025.100718","DOIUrl":"10.1016/j.prmcm.2025.100718","url":null,"abstract":"<div><h3>Background</h3><div>Hesperetin and naringenin are the two flavonoids that are widely applied in Traditional Chinese Medicine (TCM) and mostly found in citrus fruits. Both flavonoids have shown considerable neuroprotective potential. These substances originate from glycosidic precursors, hesperidin and naringin, which are chiefly found in medicinal plants like <em>Zanthoxylum avicennae</em> and <em>Citrus reticulata</em>. In TCM, these botanicals are historically utilized for their analgesic, anti-inflammatory, and digestive properties, but their potential in influencing neurodegenerative processes is receiving growing scrutiny.</div></div><div><h3>Objective</h3><div>The aim of this review is to cumulate the neuroprotective properties by systematically retrieving the peer-reviewed preclinical and clinical trial research and studies performed in hesperetin and naringenin on multiple mechanisms connected with AD.</div></div><div><h3>Methods</h3><div>A complete systematic review has been employed by applying MeSH search terms through the application of keywords such as “Alzheimer’s Disease”, “Neuroprotection”, “amyloid”, molecular mechanistic pathways of AD which are discussed in this review and “Clinical trials” for the polyphenols naringenin and hesperetin. Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) analysis method was used for screening of the research studies conducted on naringenin and hesperetin.</div></div><div><h3>Results and discussion</h3><div>The review retrieved 319 articles in respect to the hesperetin and naringenin on neurodegenerative diseases related to AD. Further scrutinised to 87 with terms of decrease of amyloid-beta aggregation, prevention of tau hyperphosphorylation, mitigation of oxidative stress, and suppression of neuroinflammation. Furthermore, they affect essential molecular cascades, including the PI3K/AKT, NRF2/ARE, and NF-κB signalling pathways, which are intricate for neuronal survival and cognition. It was also found that their ability to cross the blood-brain barrier further amplifies their pharmacological significance in central nervous system illnesses.</div></div><div><h3>Conclusion</h3><div>Hesperetin and naringenin, as natural multifunctional agents derived from traditional practices, present intriguing opportunities for integrative treatment approaches to AD, connecting the insights of TCM with contemporary neuropharmacology. Further, our review reveals several mechanisms; hesperetin and naringenin are yet to be evaluated in aspects of the hypothalamic-pituitary-adrenal axis (HPA) associated with the stress pathway of neurodegeneration, and exploring the HPA renders additional mechanistic neuroprotective recognition.</div></div>","PeriodicalId":101013,"journal":{"name":"Pharmacological Research - Modern Chinese Medicine","volume":"17 ","pages":"Article 100718"},"PeriodicalIF":0.0,"publicationDate":"2025-11-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145579081","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-11-07DOI: 10.1016/j.prmcm.2025.100717
Maryam Adamu , Olusola B. Adewale , Scholastica O. Anadozie
Introduction
Acute lung injury (ALI), one of the contributing factors of global mortality (about 40% of hospital deaths), is primarily associated with inflammatory responses and oxidative stress. Illicium verum, commonly called Ba jiao hui xiang (八角茴香) or Chinese star anise, is native to the subtropical provinces of Southwestern China and used in traditional Chinese medicine (TCM) to treat digestive disorders, insomnia, and colds, and as a spice in Chinese cuisines. This study investigated the protective effect of polyphenolic-rich extract of Illicium verum (PEIV) fruit against lipopolysaccharide (LPS)-induced ALI in rats.
Methodology
Phytochemicals in the plant was screened using high performance liquid chromatography (HPLC). Thirty-five male Wistar rats were grouped into seven as follows: Control, ALI (250 µg/kg LPS via intraperitoneal injection for 5 days), ALI + silymarin, ALI + PEIV (25, 50 and 100 mg/kg), and PEIV (100 mg/kg) via oral administration for 14 days. At the end of the experimental study, lung tissues were collected for biochemical (oxidative stress and pro-inflammatory (interleukin 6 (IL-6) and tumor necrosis factor-alpha (TNF-α)) and histological assays.
Results
Fourteen distinct biological compounds were identified by the HPLC analysis, with cinnamic acid being the most abundant, at a concentration of 58.99 µg/100 g. The LPS markedly (p < 0.05) increased the tissue arginase activity and levels of malondialdehyde (MDA), TNF-α, and IL-6. Also, a significant (p < 0.05) decrease was noted in the levels of nitric oxide (NO) and reduced glutathione (GSH), as well as the activities of enzymatic antioxidants (superoxide dismutase (SOD) and glutathione-s-transferase (GST)). However, pretreatment with PEIV protected the rats from LPS-induced ALI by a significant (p < 0.05) reduction in the arginase activity and MDA levels and elevation (p < 0.05) in the NO level and activities of antioxidant enzymes. Furthermore, PEIV reduced the levels of cytokines and reversed histological alterations induced by LPS.
Conclusion
The result of this study showed that PEIV protected the rats from LPS-induced ALI by suppressing oxidative stress and inflammation and, therefore, could be considered a promising anti-inflammatory agent in managing ALI.
{"title":"Polyphenolic-rich extract of Illicium verum fruit modulates inflammation in lipopolysaccharide-induced acute lung injury in rats","authors":"Maryam Adamu , Olusola B. Adewale , Scholastica O. Anadozie","doi":"10.1016/j.prmcm.2025.100717","DOIUrl":"10.1016/j.prmcm.2025.100717","url":null,"abstract":"<div><h3>Introduction</h3><div>Acute lung injury (ALI), one of the contributing factors of global mortality (about 40% of hospital deaths), is primarily associated with inflammatory responses and oxidative stress. <em>Illicium verum</em>, commonly called Ba jiao hui xiang <em>(八角茴香)</em> or Chinese star anise, is native to the subtropical provinces of Southwestern China and used in traditional Chinese medicine (TCM) to treat digestive disorders, insomnia, and colds, and as a spice in Chinese cuisines. This study investigated the protective effect of polyphenolic-rich extract of Illicium verum (PEIV) fruit against lipopolysaccharide (LPS)-induced ALI in rats.</div></div><div><h3>Methodology</h3><div>Phytochemicals in the plant was screened using high performance liquid chromatography (HPLC). Thirty-five male Wistar rats were grouped into seven as follows: Control, ALI (250 µg/kg LPS via intraperitoneal injection for 5 days), ALI + silymarin, ALI + PEIV (25, 50 and 100 mg/kg), and PEIV (100 mg/kg) via oral administration for 14 days. At the end of the experimental study, lung tissues were collected for biochemical (oxidative stress and pro-inflammatory (interleukin 6 (IL-6) and tumor necrosis factor-alpha (TNF-α)) and histological assays.</div></div><div><h3>Results</h3><div>Fourteen distinct biological compounds were identified by the HPLC analysis, with cinnamic acid being the most abundant, at a concentration of 58.99 µg/100 g. The LPS markedly (<em>p</em> < 0.05) increased the tissue arginase activity and levels of malondialdehyde (MDA), TNF-α, and IL-6. Also, a significant (<em>p</em> < 0.05) decrease was noted in the levels of nitric oxide (NO) and reduced glutathione (GSH), as well as the activities of enzymatic antioxidants (superoxide dismutase (SOD) and glutathione-s-transferase (GST)). However, pretreatment with PEIV protected the rats from LPS-induced ALI by a significant (<em>p</em> < 0.05) reduction in the arginase activity and MDA levels and elevation (<em>p</em> < 0.05) in the NO level and activities of antioxidant enzymes. Furthermore, PEIV reduced the levels of cytokines and reversed histological alterations induced by LPS.</div></div><div><h3>Conclusion</h3><div>The result of this study showed that PEIV protected the rats from LPS-induced ALI by suppressing oxidative stress and inflammation and, therefore, could be considered a promising anti-inflammatory agent in managing ALI.</div></div>","PeriodicalId":101013,"journal":{"name":"Pharmacological Research - Modern Chinese Medicine","volume":"17 ","pages":"Article 100717"},"PeriodicalIF":0.0,"publicationDate":"2025-11-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145528410","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-11-05DOI: 10.1016/j.prmcm.2025.100716
Rajashekar S. Chavan , Nayeem A. Khatib , Vishal S. Patil , Jagadeesh Dodakallanavar
Background
Metabolic syndrome (MetS) is a multifactorial disorder characterized by abdominal obesity, insulin resistance (IR), hypertension, dyslipidemia, and an increased risk of type 2 diabetes mellitus (T2DM) and cardiovascular diseases (CVDs). Conventional pharmacological interventions primarily manage symptoms but are associated with adverse effects. Bioactive compounds from medicinal plants offer promising multi-targeted therapeutic benefits. This study evaluates the efficacy of a polyherbal formulation containing extracts of Nigella sativa (NS, seed), Momordica charantia (MC, fruit), and Anethum graveolens (AG, fruit) in mitigating MetS-induced complications in an olanzapine (Zyprexa)-induced MetS rat model.
Methods
Animals were divided into five groups: normal control (saline), disease control (olanzapine (Zyprexa) 2 mg/kg, i.p., twice daily), and three treatment groups receiving olanzapine (Zyprexa) with formulations containing combination of NS, MC, and AG at 200 mg/kg (100:50:50), 400 mg/kg (200:100:100), and 800 mg/kg (400:200:200) orally. The study assessed metabolic parameters, including blood glucose levels, body weight, food and water intake, lipid profile, and Hemoglobin A1c/ glycated hemoglobin (HbA1c) levels. Cardiac activity function was evaluated using electrocardiography (ECG). Antioxidant status was assessed by estimating superoxide dismutase (SOD), catalase (CAT), and reduced glutathione (GSH) levels in tissue homogenates of the heart, liver, and pancreas. Histopathological examinations of these organs were also performed.
Results
Polyherbal formulation 800 mg/kg (400:200:200 ratio) significantly reduced blood glucose levels, improved lipid profiles, and mitigated weight gain induced by olanzapine (Zyprexa). ECG analysis demonstrated cardioprotective effects. Antioxidant enzyme activity, including SOD, CAT, and GSH levels, was notably improved in tissue homogenates. Histopathological evaluation further confirmed the protective effects on the liver, heart, and pancreas.
Conclusion
The findings suggest that the polyherbal formulation exerts protective effects against MetS by ameliorating blood glucose levels, improving lipid profile, enhancing antioxidant status, and preserving tissue architecture, thereby highlighting its potential as a natural therapeutic alternative for the management of metabolic syndrome.
{"title":"Therapeutic potential of a combination of Nigella sativa, Momordica charantia, and Anethum graveolens in metabolic syndrome management: An in vivo study","authors":"Rajashekar S. Chavan , Nayeem A. Khatib , Vishal S. Patil , Jagadeesh Dodakallanavar","doi":"10.1016/j.prmcm.2025.100716","DOIUrl":"10.1016/j.prmcm.2025.100716","url":null,"abstract":"<div><h3>Background</h3><div>Metabolic syndrome (MetS) is a multifactorial disorder characterized by abdominal obesity, insulin resistance (IR), hypertension, dyslipidemia, and an increased risk of type 2 diabetes mellitus (T2DM) and cardiovascular diseases (CVDs). Conventional pharmacological interventions primarily manage symptoms but are associated with adverse effects. Bioactive compounds from medicinal plants offer promising multi-targeted therapeutic benefits. This study evaluates the efficacy of a polyherbal formulation containing extracts of <em>Nigella sativa</em> (NS, seed), <em>Momordica charantia</em> (MC, fruit), and <em>Anethum graveolens</em> (AG, fruit) in mitigating MetS-induced complications in an olanzapine (Zyprexa)-induced MetS rat model.</div></div><div><h3>Methods</h3><div>Animals were divided into five groups: normal control (saline), disease control (olanzapine (Zyprexa) 2 mg/kg, i.p., twice daily), and three treatment groups receiving olanzapine (Zyprexa) with formulations containing combination of NS, MC, and AG at 200 mg/kg (100:50:50), 400 mg/kg (200:100:100), and 800 mg/kg (400:200:200) orally. The study assessed metabolic parameters, including blood glucose levels, body weight, food and water intake, lipid profile, and Hemoglobin A1c/ glycated hemoglobin (HbA1c) levels. Cardiac activity function was evaluated using electrocardiography (ECG). Antioxidant status was assessed by estimating superoxide dismutase (SOD), catalase (CAT), and reduced glutathione (GSH) levels in tissue homogenates of the heart, liver, and pancreas. Histopathological examinations of these organs were also performed.</div></div><div><h3>Results</h3><div>Polyherbal formulation 800 mg/kg (400:200:200 ratio) significantly reduced blood glucose levels, improved lipid profiles, and mitigated weight gain induced by olanzapine (Zyprexa). ECG analysis demonstrated cardioprotective effects. Antioxidant enzyme activity, including SOD, CAT, and GSH levels, was notably improved in tissue homogenates. Histopathological evaluation further confirmed the protective effects on the liver, heart, and pancreas.</div></div><div><h3>Conclusion</h3><div>The findings suggest that the polyherbal formulation exerts protective effects against MetS by ameliorating blood glucose levels, improving lipid profile, enhancing antioxidant status, and preserving tissue architecture, thereby highlighting its potential as a natural therapeutic alternative for the management of metabolic syndrome.</div></div>","PeriodicalId":101013,"journal":{"name":"Pharmacological Research - Modern Chinese Medicine","volume":"17 ","pages":"Article 100716"},"PeriodicalIF":0.0,"publicationDate":"2025-11-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145528411","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-11-01DOI: 10.1016/j.prmcm.2025.100715
Shi Qi Xu , Wenchao Gong , Wenjie Qin , Dong-Hwa Chung , De Xin Dang
Background
Reactive oxygen species (ROS) are generated under both physiological and pathological conditions, including strenuous exercise, inflammation, and unhealthy dietary intake. Excessive ROS accumulation induces oxidative stress, which damages cellular components and contributes to the onset and progression of chronic diseases. Efficient elimination of ROS is therefore essential for maintaining redox homeostasis and promoting health. Antioxidant peptides derived from herbal medicines have recently gained increasing attention due to their natural origin, safety, and multifunctional biological activities. Compared with synthetic antioxidants, which may raise safety concerns with long-term use, these bioactive peptides represent a promising alternative.
Purpose
This study aimed to investigate Humulus scandens (HS), a traditional herbal medicine with reported antioxidant capacity, as a potential source of novel antioxidant peptides.
Methods
A systematic in silico workflow was applied, integrating virtual screening, molecular docking, ligand efficiency analysis, and molecular dynamics simulations. Keap1, a critical regulator of oxidative stress signaling, was selected as the molecular target.
Results
Seven candidate peptides were identified based on predicted non-toxicity, bioactivity, and favorable intestinal absorption. Among these, the tripeptide PGW demonstrated the greatest potential. Molecular docking revealed that PGW interacts with Keap1 through 10 hydrogen bonds, 1 hydrophobic interaction, and 22 van der Waals forces. Subsequent molecular dynamics simulations confirmed the stability of the PGW-Keap1 complex and supported its strong binding affinity.
Conclusions
The tripeptide PGW, derived from HS protein, exhibits promising antioxidant potential through direct interaction with Keap1. These findings highlight PGW as a candidate for development into functional food ingredients or nutraceuticals aimed at preventing oxidative stress-related disorders.
{"title":"Discovery of antioxidant peptides from Humulus scandens by multi-step virtual screening, molecular docking, ligand efficiency analysis, and molecular dynamics simulation","authors":"Shi Qi Xu , Wenchao Gong , Wenjie Qin , Dong-Hwa Chung , De Xin Dang","doi":"10.1016/j.prmcm.2025.100715","DOIUrl":"10.1016/j.prmcm.2025.100715","url":null,"abstract":"<div><h3>Background</h3><div>Reactive oxygen species (ROS) are generated under both physiological and pathological conditions, including strenuous exercise, inflammation, and unhealthy dietary intake. Excessive ROS accumulation induces oxidative stress, which damages cellular components and contributes to the onset and progression of chronic diseases. Efficient elimination of ROS is therefore essential for maintaining redox homeostasis and promoting health. Antioxidant peptides derived from herbal medicines have recently gained increasing attention due to their natural origin, safety, and multifunctional biological activities. Compared with synthetic antioxidants, which may raise safety concerns with long-term use, these bioactive peptides represent a promising alternative.</div></div><div><h3>Purpose</h3><div>This study aimed to investigate Humulus scandens (HS), a traditional herbal medicine with reported antioxidant capacity, as a potential source of novel antioxidant peptides.</div></div><div><h3>Methods</h3><div>A systematic in silico workflow was applied, integrating virtual screening, molecular docking, ligand efficiency analysis, and molecular dynamics simulations. Keap1, a critical regulator of oxidative stress signaling, was selected as the molecular target.</div></div><div><h3>Results</h3><div>Seven candidate peptides were identified based on predicted non-toxicity, bioactivity, and favorable intestinal absorption. Among these, the tripeptide PGW demonstrated the greatest potential. Molecular docking revealed that PGW interacts with Keap1 through 10 hydrogen bonds, 1 hydrophobic interaction, and 22 van der Waals forces. Subsequent molecular dynamics simulations confirmed the stability of the PGW-Keap1 complex and supported its strong binding affinity.</div></div><div><h3>Conclusions</h3><div>The tripeptide PGW, derived from HS protein, exhibits promising antioxidant potential through direct interaction with Keap1. These findings highlight PGW as a candidate for development into functional food ingredients or nutraceuticals aimed at preventing oxidative stress-related disorders.</div></div>","PeriodicalId":101013,"journal":{"name":"Pharmacological Research - Modern Chinese Medicine","volume":"17 ","pages":"Article 100715"},"PeriodicalIF":0.0,"publicationDate":"2025-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145528540","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-11-01DOI: 10.1016/j.prmcm.2025.100714
Sourav Pal , Arghya Panda , Biprojit Bhowmick , Khokan Bera
Introduction
Crithmum maritimum(sea fennel, Chinese: 海茴香 [hǎi huí xiāng]) is an edible halophyte traditionally valued in both Mediterranean diets and Traditional Chinese Medicine (TCM), where it is prescribed for “dissolving masses,” regulating qi, and resolving damp-heat/toxins—concepts aligned with anti-inflammatory, antimicrobial, and anticancer effects. Rich in phenolic acids, flavonoids, essential oils, fatty acids, vitamins, and minerals, it shows potential against gastrointestinal tract (GIT) cancers, a growing global health burden.
Methods
A systematic literature search was conducted in PubMed, Scopus, Web of Science, and Google Scholar for studies published between 2010 and 2025, limited to English language studies, using keywords “Crithmum maritimum,” “sea fennel,” “gastrointestinal cancer,” “anticancer,” “polyphenols,” “essential oils,” and “bioactive compounds.” of 167 retrieved records, 138 met the inclusion criteria: original in vitro, in vivo, or clinical research evaluating C. maritimum or its constituents for anticancer activity in GIT malignancies. Exclusion criteria removed reviews without new data, unrelated species, and studies lacking mechanistic outcomes.
Results
C. maritimum exhibits preclinical efficacy against GIT cancers via modulation of p53, NRF2, and Wnt/β-catenin pathways, aligning with its traditional TCM uses. Studies identified chlorogenic acid (30–50 % of total polyphenol), gallic acid (15–20 % of terpene), limonene, sabinene, α-pinene, γ-terpinene, fatty acids, and vitamin C as key anticancer agents that promote apoptosis, inhibit angiogenesis, and attenuate oxidative and inflammatory signaling in GIT cancer models.
Conclusion
C. maritimum exhibits a broad phytochemical spectrum with multitargeted preclinical efficacy against GIT cancers, consistent with its historical TCM applications. Standardization, mechanistic validation, and clinical trials are required to advance its therapeutic integration.
Significance Statement
This review unites TCM tradition with modern biomedical evidence, highlighting C. maritimum as a promising natural agent for GIT cancer prevention and management, with mechanistic breadth well-suited to the multifactorial nature of these malignancies.
{"title":"Crithmum maritimum: Phytoconstituents composition, and potential anticancer activity in gastrointestinal cancer mechanisms and prospects","authors":"Sourav Pal , Arghya Panda , Biprojit Bhowmick , Khokan Bera","doi":"10.1016/j.prmcm.2025.100714","DOIUrl":"10.1016/j.prmcm.2025.100714","url":null,"abstract":"<div><h3>Introduction</h3><div><em>Crithmum maritimum</em>(sea fennel, Chinese: 海茴香 [hǎi huí xiāng]) is an edible halophyte traditionally valued in both Mediterranean diets and Traditional Chinese Medicine (TCM), where it is prescribed for “dissolving masses,” regulating qi, and resolving damp-heat/toxins—concepts aligned with anti-inflammatory, antimicrobial, and anticancer effects. Rich in phenolic acids, flavonoids, essential oils, fatty acids, vitamins, and minerals, it shows potential against gastrointestinal tract (GIT) cancers, a growing global health burden.</div></div><div><h3>Methods</h3><div>A systematic literature search was conducted in PubMed, Scopus, Web of Science, and Google Scholar for studies published between 2010 and 2025, limited to English language studies, using keywords “Crithmum maritimum,” “sea fennel,” “gastrointestinal cancer,” “anticancer,” “polyphenols,” “essential oils,” and “bioactive compounds.” of 167 retrieved records, 138 met the inclusion criteria: original in vitro, in vivo, or clinical research evaluating <em>C. maritimum</em> or its constituents for anticancer activity in GIT malignancies. Exclusion criteria removed reviews without new data, unrelated species, and studies lacking mechanistic outcomes.</div></div><div><h3>Results</h3><div><em>C. maritimum</em> exhibits preclinical efficacy against GIT cancers via modulation of p53, NRF2, and Wnt/β-catenin pathways, aligning with its traditional TCM uses. Studies identified chlorogenic acid (30–50 % of total polyphenol), gallic acid (15–20 % of terpene), limonene, sabinene, α-pinene, γ-terpinene, fatty acids, and vitamin C as key anticancer agents that promote apoptosis, inhibit angiogenesis, and attenuate oxidative and inflammatory signaling in GIT cancer models.</div></div><div><h3>Conclusion</h3><div><em>C. maritimum</em> exhibits a broad phytochemical spectrum with multitargeted preclinical efficacy against GIT cancers, consistent with its historical TCM applications. Standardization, mechanistic validation, and clinical trials are required to advance its therapeutic integration.</div></div><div><h3>Significance Statement</h3><div>This review unites TCM tradition with modern biomedical evidence, highlighting <em>C. maritimum</em> as a promising natural agent for GIT cancer prevention and management, with mechanistic breadth well-suited to the multifactorial nature of these malignancies.</div></div>","PeriodicalId":101013,"journal":{"name":"Pharmacological Research - Modern Chinese Medicine","volume":"17 ","pages":"Article 100714"},"PeriodicalIF":0.0,"publicationDate":"2025-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145466300","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-10-26DOI: 10.1016/j.prmcm.2025.100713
Dilpreet Singh , Nandni , Neena Bedi
Introduction
Honokiol (厚朴酚, Hou Po Fen), a biphenolic compound derived from the bark of Magnolia officinalis (厚朴, Hou Po), has emerged as a promising phytochemical with multi-target pharmacological activities. Traditionally used in East Asian medicine, it is now being investigated for applications in cancer, neurodegenerative disorders, inflammation, and infectious diseases. Its therapeutic promise is attributed to its ability to modulate critical signaling pathways including NF-κB, STAT3, PI3K/Akt/mTOR, and Nrf2.
Methods
This review synthesizes and critically analyzes published evidence on honokiol’s chemical properties, mechanisms of action, pharmacological activities, and nanotechnology-based delivery systems. Literature was sourced from PubMed, Scopus, and Web of Science databases, focusing on preclinical, clinical, and formulation studies of honokiol between 2000–2025. Key molecular targets, in vitro and in vivo efficacy, and translational challenges were evaluated and summarized.
Results
Honokiol demonstrates potent antioxidant, anti-inflammatory, anticancer, antimicrobial, and neuroprotective activities. It effectively induces apoptosis, inhibits angiogenesis, and modulates tumor microenvironmental factors. Neuroprotective actions include attenuation of neuroinflammation, preservation of mitochondrial function, and improvement of cognitive performance. Nanocarrier-based systems—such as liposomes, polymeric nanoparticles, micelles, and nanoemulsions—significantly improve honokiol’s solubility, stability, and bioavailability. Preclinical data confirm efficacy across cancer, neurological, and inflammatory models, though clinical evidence remains limited.
Discussion
Honokiol represents a promising next-generation phytotherapeutic candidate bridging traditional Chinese medicine and modern molecular pharmacology. Despite strong preclinical support, translational progress is hindered by low water solubility, poor bioavailability, limited clinical trials, and regulatory challenges. Advances in nanotechnology, epigenetic modulation, and personalized medicine approaches may accelerate clinical adoption. Future research should focus on standardized formulations, biomarker-driven trials, and integration with emerging therapeutic technologies.
厚朴酚(honokiol,简称:厚朴酚酚)是一种从厚朴树皮中提取的双酚类化合物,是一种具有多靶点药理活性的植物化学物质。传统上用于东亚医学,现在正在研究它在癌症、神经退行性疾病、炎症和传染病方面的应用。其治疗前景归因于其调节关键信号通路的能力,包括NF-κB、STAT3、PI3K/Akt/mTOR和Nrf2。方法本综述综合并批判性地分析了已发表的关于厚朴酚的化学性质、作用机制、药理活性和基于纳米技术的递送系统的证据。文献来源于PubMed、Scopus和Web of Science数据库,重点是2000-2025年间对檀香醇的临床前、临床和配方研究。对关键分子靶点、体外和体内疗效以及转化挑战进行了评价和总结。结果鲜木酚具有较强的抗氧化、抗炎、抗癌、抗菌和神经保护活性。它能有效诱导细胞凋亡,抑制血管生成,调节肿瘤微环境因子。神经保护作用包括神经炎症的衰减、线粒体功能的保存和认知能力的改善。纳米载体为基础的系统,如脂质体,聚合物纳米颗粒,胶束和纳米乳液,显著提高了厚朴醇的溶解度,稳定性和生物利用度。临床前数据证实了该药物在癌症、神经和炎症模型中的有效性,但临床证据仍然有限。本木酚是一种很有前途的新一代植物治疗候选者,它连接了传统中药和现代分子药理学。尽管有强大的临床前支持,但由于水溶性低、生物利用度差、临床试验有限和监管方面的挑战,转化进展受到阻碍。纳米技术、表观遗传调节和个性化医疗方法的进步可能会加速临床应用。未来的研究应侧重于标准化配方、生物标志物驱动的试验以及与新兴治疗技术的整合。
{"title":"Honokiol as a next-generation phytotherapeutic: Anticancer, neuroprotective, and nanomedicine perspectives","authors":"Dilpreet Singh , Nandni , Neena Bedi","doi":"10.1016/j.prmcm.2025.100713","DOIUrl":"10.1016/j.prmcm.2025.100713","url":null,"abstract":"<div><h3>Introduction</h3><div>Honokiol (<strong>厚朴酚, Hou Po Fen</strong>), a biphenolic compound derived from the bark of <em>Magnolia officinalis</em> (<strong>厚朴, Hou Po</strong>), has emerged as a promising phytochemical with multi-target pharmacological activities. Traditionally used in East Asian medicine, it is now being investigated for applications in cancer, neurodegenerative disorders, inflammation, and infectious diseases. Its therapeutic promise is attributed to its ability to modulate critical signaling pathways including NF-κB, STAT3, PI3K/Akt/mTOR, and Nrf2.</div></div><div><h3>Methods</h3><div>This review synthesizes and critically analyzes published evidence on honokiol’s chemical properties, mechanisms of action, pharmacological activities, and nanotechnology-based delivery systems. Literature was sourced from PubMed, Scopus, and Web of Science databases, focusing on preclinical, clinical, and formulation studies of honokiol between 2000–2025. Key molecular targets, in vitro and in vivo efficacy, and translational challenges were evaluated and summarized.</div></div><div><h3>Results</h3><div>Honokiol demonstrates potent antioxidant, anti-inflammatory, anticancer, antimicrobial, and neuroprotective activities. It effectively induces apoptosis, inhibits angiogenesis, and modulates tumor microenvironmental factors. Neuroprotective actions include attenuation of neuroinflammation, preservation of mitochondrial function, and improvement of cognitive performance. Nanocarrier-based systems—such as liposomes, polymeric nanoparticles, micelles, and nanoemulsions—significantly improve honokiol’s solubility, stability, and bioavailability. Preclinical data confirm efficacy across cancer, neurological, and inflammatory models, though clinical evidence remains limited.</div></div><div><h3>Discussion</h3><div>Honokiol represents a promising next-generation phytotherapeutic candidate bridging traditional Chinese medicine and modern molecular pharmacology. Despite strong preclinical support, translational progress is hindered by low water solubility, poor bioavailability, limited clinical trials, and regulatory challenges. Advances in nanotechnology, epigenetic modulation, and personalized medicine approaches may accelerate clinical adoption. Future research should focus on standardized formulations, biomarker-driven trials, and integration with emerging therapeutic technologies.</div></div>","PeriodicalId":101013,"journal":{"name":"Pharmacological Research - Modern Chinese Medicine","volume":"17 ","pages":"Article 100713"},"PeriodicalIF":0.0,"publicationDate":"2025-10-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145466289","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}